Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial
Massachusetts General Hospital researchers complete first study comparing commonly used type 2 diabetes medications.
Deborah J. Wexler, MD, MSc, is Associate Professor of Medicine at Harvard Medical School, Boston, Massachusetts, the Associate Clinical Chief of the MGH Diabetes Unit, and Clinical Director of the MGH Diabetes Center. She received her medical degree from Yale University School of Medicine, New Haven, Connecticut, her MSc from the University of Oxford, and completed her internship, residency, and chief residency in internal medicine and fellowship in endocrinology at Massachusetts General Hospital.
Dr. Wexler’s research focuses on clinical effectiveness in type 2 diabetes. She is the MGH site Principal Investigator and is on the Executive Committee of the GRADE Study, a NIH-funded multicenter trial to determine which second hypoglycemic drug, added to metformin, is most effective for patients with type 2 diabetes (http://gradestudy.com/). She is also multiple-Principal Investigator of the REAL HEALTH-Diabetes trial, which is translating the Look AHEAD lifestyle intervention for type 2 diabetes into usual care at community health centers. She served on the American Diabetes Association’s Professional Practice Committee (2014-2016) and was a co-author of the ADA-EASD position statement on management of hyperglycemia in type 2 diabetes. Dr Wexler is on the Editorial Board of Diabetes Care and is a reviewer for multiple medical journals.
Clinical Interests:
Treats:
Mass General Endocrinology: Diabetes Clinical Center
50 Staniford St.
Suite 340
Boston, MA 02114
Phone: 617-726-8720
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2023-2024.
Massachusetts General Hospital researchers complete first study comparing commonly used type 2 diabetes medications.
Researchers from Mass General shed light on whether newly diagnosed diabetes in COVID-19 patients is truly new or merely previously undiagnosed